University of Pittsburgh School of Medicine announced that the vaccine, when tested in mice, produces antibodies specific to the coronavirus SARS-CoV-2 that could be enough to fight off the virus. https://t.co/kS718NLwMU

— TribLIVE.com (@TribLIVE) April 2, 2020